Narnolia

Narnolia

Toll Free No: 1800-103-7212

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE286.456.15 (+2.19 %)
PREV CLOSE ( ) 280.30
OPEN PRICE ( ) 280.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 66957
TODAY'S LOW / HIGH ( )277.40 287.20
52 WK LOW / HIGH ( )269.75 706.9
NSE286.456.25 (+2.23 %)
PREV CLOSE( ) 280.20
OPEN PRICE ( ) 280.50
BID PRICE (QTY) 286.45 (15)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1248986
TODAY'S LOW / HIGH( ) 277.25 287.40
52 WK LOW / HIGH ( )270 705.9
Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)32.7828.4939.3026.347.72
   CEPS(Rs)44.3339.1948.6634.6418.79
   DPS(Rs)2.002.002.002.002.00
   Book NAV/Share(Rs)198.27182.62159.16128.5965.74
   Tax Rate(%)28.8828.1825.6628.8361.46
Margin Ratios
   Core EBITDA Margin(%)16.0717.7522.1718.7917.96
   EBIT Margin(%)16.5815.4318.8215.9910.85
   Pre Tax Margin(%)13.1812.3016.2413.658.04
   PAT Margin (%)9.388.8312.079.713.10
   Cash Profit Margin (%)12.6812.1514.9512.787.54
Performance Ratios
   ROA(%)7.987.4011.338.522.58
   ROE(%)17.2116.6727.3127.468.79
   ROCE(%)16.4714.7720.5418.5312.40
   Asset Turnover(x)0.850.840.940.880.83
   Sales/Fixed Asset(x)1.661.802.031.961.90
   Working Capital/Sales(x)3.692.462.204.024.35
Efficiency Ratios
   Fixed Capital/Sales(x)0.600.560.490.510.53
   Receivable days83.7394.9597.29119.39125.97
   Inventory Days79.2283.5973.6567.6859.42
   Payable days97.4396.28101.59117.0395.22
Valuation Parameters
   PER(x)19.6918.5121.8330.15101.76
   PCE(x)14.5613.4517.6322.9341.82
   Price/Book(x)3.262.895.396.1811.96
   Yield(%)0.310.380.230.250.25
   EV/Net Sales(x)2.202.013.073.383.64
   EV/Core EBITDA(x)12.1110.7113.4417.5319.94
   EV/EBIT(x)13.2913.0116.1220.8933.18
   EV/CE(x)1.821.622.672.802.93
   M Cap / Sales1.851.642.672.963.19
Growth Ratio
   Net Sales Growth(%)8.72-0.0620.0713.1812.38
   Core EBITDA Growth(%)5.11-17.7142.3419.3210.79
   EBIT Growth(%)16.39-18.7341.3766.67-17.14
   PAT Growth(%)15.07-27.5049.22254.72-61.61
   EPS Growth(%)15.08-27.5149.18241.03-61.37
Financial Stability Ratios
   Total Debt/Equity(x)0.800.901.051.102.13
   Current Ratio(x)1.672.132.541.481.41
   Quick Ratio(x)1.111.511.751.081.08
   Interest Cover(x)4.894.927.286.843.86
   Total Debt/Mcap(x)0.240.310.200.180.18

Directory

current IPO
  • --
upcoming IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room